bottle of semaglutide Flex-Dose 4 mL Injectable 2.5 mg/mL SkinnyRx: Injectable Semaglutide (GLP-1)

Ongoing Support Your success is our priority

Both mechanisms appear to become effective early after treatment initiation, with glycosuria continuing in the long term without any significant fluid change

The study found a higher risk of NAION in patients prescribed GLP-1 compared to those on non-GLP-1 RA medications

Your complete medical history will be evaluated, which will include a discussion of current medications, allergies, past treatments, and pre-existing conditions

PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan